These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 11289398)

  • 21. The efficacy of nanoscale poly[bis(trifluoroethoxy) phosphazene] (PTFEP) coatings in reducing thrombogenicity and late in-stent stenosis in a porcine coronary artery model.
    Satzl S; Henn C; Christoph P; Kurz P; Stampfl U; Stampfl S; Thomas F; Radeleff B; Berger I; Grunze M; Richter GM
    Invest Radiol; 2007 May; 42(5):303-11. PubMed ID: 17414526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
    Vilahur G; Segalés E; Salas E; Badimon L
    Circulation; 2004 Sep; 110(12):1686-93. PubMed ID: 15381660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-treatment of porcine pulmonary xenograft with desmopressin: a novel strategy to attenuate platelet activation and systemic intravascular coagulation in an ex-vivo model of swine-to-human pulmonary xenotransplantation.
    Kim YT; Lee HJ; Lee SW; Kim JY; Wi HC; Park SJ; Bae SJ; Kang HJ
    Xenotransplantation; 2008 Feb; 15(1):27-35. PubMed ID: 18333911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microcirculatory perfusion shift in the gut wall layers induced by extracorporeal circulation.
    Kalder J; Ajah D; Keschenau P; Kennes LN; Tolba R; Kokozidou M; Jacobs MJ; Koeppel TA
    J Vasc Surg; 2015 Feb; 61(2):497-503. PubMed ID: 24275079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biocompatibility of tetramethylpyrazine-eluting stents in normal porcine coronary arteries.
    Ma GS; Chen LJ; Chen Z; Ding S; Shen CX; Feng Y
    Biomed Pharmacother; 2008 Feb; 62(2):125-9. PubMed ID: 17764890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metallic surface modification.
    De Scheerder I; Verbeken E; Van Humbeeck J
    Semin Interv Cardiol; 1998; 3(3-4):139-44. PubMed ID: 10406683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silicon-carbide coated coronary stents have low platelet and leukocyte adhesion during platelet activation.
    Monnink SH; van Boven AJ; Peels HO; Tigchelaar I; de Kam PJ; Crijns HJ; van Oeveren W
    J Investig Med; 1999 Jul; 47(6):304-10. PubMed ID: 10431485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet reactivity in patients with subacute stent thrombosis compared with non-stent-related acute myocardial infarction.
    Lev EI; Alviar CL; Arikan ME; Dave BP; Granada JF; DeLao T; Tellez A; Maresh K; Kleiman NS
    Am Heart J; 2007 Jan; 153(1):41.e1-6. PubMed ID: 17174635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithrombotic activity of Z4A5, a new platelet glycoprotein IIb/IIIa receptor antagonist evaluated in a rabbit arteriovenous shunt thrombosis model.
    Jing BB; Li YX; Zhang H; Ren ST; Wang M; Li YP; Zang WJ; Wang B
    Thromb Res; 2011 Nov; 128(5):463-9. PubMed ID: 21924458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developing pulsatile flow in a deployed coronary stent.
    Rajamohan D; Banerjee RK; Back LH; Ibrahim AA; Jog MA
    J Biomech Eng; 2006 Jun; 128(3):347-59. PubMed ID: 16706584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronary artery overexpansion increases neointimal hyperplasia after stent placement in a porcine model.
    Russo RJ; Silva PD; Yeager M
    Heart; 2007 Dec; 93(12):1609-15. PubMed ID: 17639098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating patency rates of an ultralow-porosity expanded polytetrafluoroethylene covered stent in the treatment of venous stenosis in arteriovenous dialysis circuits.
    Chan MG; Miller FJ; Valji K; Bansal A; Kuo MD
    J Vasc Interv Radiol; 2014 Feb; 25(2):183-9. PubMed ID: 24286940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restenosis following placement of an intracoronary heparin treated tantulum stent in the hyperlipidemic miniature swine model.
    Jenkins JS; Webel R; Laughlin MH; Rowland SM; Yoklavich MF; Amann JF; Branson K; Myers PR
    J Invasive Cardiol; 1995; 7(6):173-82. PubMed ID: 10155102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial.
    Di Lorenzo E; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Stanco G; Rosato G; Suryapranata H; De Luca G
    JACC Cardiovasc Interv; 2014 Aug; 7(8):849-56. PubMed ID: 25147029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transjugular intrahepatic portosystemic shunt with an autologous endothelial progenitor cell seeded stent: a porcine model.
    Shi HJ; Cao AH; Chen J; Deng G; Teng GJ
    Acad Radiol; 2010 Mar; 17(3):358-67. PubMed ID: 19962914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries.
    Banai S; Gertz SD; Gavish L; Chorny M; Perez LS; Lazarovichi G; Ianculuvich M; Hoffmann M; Orlowski M; Golomb G; Levitzki A
    Cardiovasc Res; 2004 Oct; 64(1):165-71. PubMed ID: 15364624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High on treatment platelet reactivity and stent thrombosis.
    Rajendran S; Parikh D; Shugman I; French JK; Juergens CP
    Heart Lung Circ; 2011 Aug; 20(8):525-31. PubMed ID: 21592858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does the additional use of heparin-coated extracorporeal circuits (ECC) optimize the effect of modified ultrafiltration (MUF) in pediatric perfusion?
    Harig F; Meier C; Hakami L; Strasser R; Bretzger J; Münch F; Vestweber-Wilmes E; Singer H; Weyand M; Cesnjevar R
    Thorac Cardiovasc Surg; 2006 Apr; 54(3):168-72. PubMed ID: 16639677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of erythrocyte adhesion onto porous surfaces by fluid perfusion.
    Clarke DR; Park JB
    Biomaterials; 1981 Jan; 2(1):9-13. PubMed ID: 7236836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visualization and analysis of biomaterial-centered thrombus formation within a defined crevice under flow.
    Jamiolkowski MA; Pedersen DD; Wu WT; Antaki JF; Wagner WR
    Biomaterials; 2016 Jul; 96():72-83. PubMed ID: 27156141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.